Minimed Group Inc
NAS:MMEDHealthcareCBOEFTSE:MRUTnasdaq_composite$17.57−1.24%LiveIn session · ≈ AED 64.53 · Market cap $4.94B · Next earnings Wed 30 Dec
| USD millions | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|
| Net income | (92.0) | (107.0) | (198.0) | (317.0) | −60.1% | |
| Depreciation & amortization | 115.0 | 129.0 | 143.0 | 156.0 | +9.1% | |
| Stock-based compensation | 35.0 | 38.0 | 41.0 | 46.0 | +12.2% | |
| Change in working capital | (90.0) | (74.0) | 122.0 | (166.0) | −236.1% | |
| Operating cash flow | (6.0) | 41.0 | 140.0 | (197.0) | −240.7% | |
| Capital expenditure | (167.0) | (148.0) | (193.0) | (223.0) | −15.5% | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Investing cash flow | (180.0) | (157.0) | (193.0) | (233.0) | −20.7% | |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Share buybacks | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Debt issued / repaid | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Financing cash flow | 185.0 | 112.0 | 10.0 | 716.0 | +7060.0% | |
| Free cash flow | (173.0) | (107.0) | (53.0) | (420.0) | −692.5% | |
| Net change in cash | (2.0) | (4.0) | (43.0) | 287.0 | +767.4% |
USD millionsUpdated Tue 8 Sep ·
ⓘ
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
